Skip to main content
ImmuneCited

Vitamin E per Immune Aging (Immunosenescence)

B

Clinical trials in elderly populations demonstrate vitamin E supplementation at 200 IU/day may enhance delayed-type hypersensitivity (DTH) skin test response and antibody production. Recognized as one of the most effective single nutrients for modulating immune function in older adults.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dvitamin\u002De\u0026condition\u003Dimmunosenescence'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

In sintesi

Clinical trials in elderly populations demonstrate vitamin E supplementation at 200 IU/day may enhance delayed-type hypersensitivity (DTH) skin test response and antibody production. Recognized as one of the most effective single nutrients for modulating immune function in older adults.

Key Study Findings

Review
Micronutrient Deficiencies in Pediatric IBD: How Often, Why, and What to Do?
Dose: None vs: None Outcome: Micronutrient deficiency management in pediatric IBD Effetto: None None

Popolazione: Children with inflammatory bowel disease (review)

Observational Study n=2065
Cytomegalovirus (CMV), oxidative stress, and inflammation: implications for immunosenescence and age-related diseases in the MARK-AGE …
Dose: None vs: None Outcome: CMV IgG association with oxidative stress markers Effetto: None None

Popolazione: Age-stratified general population (MARK-AGE RASIG cohort)

In Vitro
Anti-Hair Loss Potential of Perilla Seed Extracts: In Vitro Molecular Insights from Supercritical Fluid Extraction.
Dose: None vs: Untreated HFDPCs; finasteride, dutasteride, minoxidil Outcome: SRD5A1-3 and TGF-beta1 expression Effetto: HFDPC proliferation 139.4+/-1.1% at 72h p<0.05

Popolazione: Human hair follicle dermal papilla cells (in vitro)

Review
Nutrition, Immunosenescence, and Infectious Disease: An Overview of the Scientific Evidence on Micronutrients and on …
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: Elderly with immunosenescence

Other
The impact of vitamin E and/or selenium dietary supplementation on growth parameters and expression levels …
Dose: 100 mg vs: control Outcome: None Effetto: or 1 None

Popolazione: None

Review n=26282 988 weeks
Inadequacy of Immune Health Nutrients: Intakes in US Adults, the 2005-2016 NHANES.
Dose: 45% vs: None Outcome: None Effetto: None None

Popolazione: None

Key Statistics

5

Studi

600

Partecipanti

Positive

B

Grado

Referenced Papers

World journal of … 2015 62 citazioni
Annual review of … 2014 9 citazioni
Aging and disease 2012 209 citazioni
Journal of comparative … 2010 17 citazioni
The British journal … 2002 358 citazioni

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

general:
15 mg/day (22.4 IU)
immunesupportelderly:
200 IU/day

Limite massimo: 1,000 mg/day (1,500 IU natural, 1,100 IU synthetic)

Dosaggi studiati nella ricerca

Dosaggio Durata Effetto N
None -- Neutral --
None -- Negative 2065
None -- Positive --
None -- Mixed --
100 mg -- Positive --
45% 988 weeks Positive 26282
500 mg 12 weeks Mixed --
None -- Mixed --

Momento migliore per l'assunzione: With meals containing fat

Safety & Side Effects

Effetti collaterali segnalati

  • Increased bleeding risk at high doses (>400 IU/day)
  • Nausea and gastrointestinal distress
  • Fatigue and muscle weakness at very high doses
  • Potential increased mortality risk at chronic high doses (meta-analysis finding, debated)

Interazioni note

  • Anticoagulants and antiplatelet drugs (increased bleeding risk)
  • Statins (may reduce statin effectiveness)
  • Chemotherapy agents (may interfere with oxidative mechanisms)
  • Vitamin K (high-dose vitamin E may antagonize vitamin K)

Livello di assunzione massimo tollerabile: 1,000 mg/day (1,500 IU natural, 1,100 IU synthetic)

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Vitamin E help with Immune Aging (Immunosenescence)?
Based on 5 studies with 600 participants, there is moderate evidence from clinical studies that Vitamin E may support Immune Aging (Immunosenescence) management. Our evidence grade is B (Good Evidence).
How much Vitamin E should I take for Immune Aging (Immunosenescence)?
Studies have used various dosages. A commonly studied range is 15 mg/day (22.4 IU). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Vitamin E?
Reported side effects may include Increased bleeding risk at high doses (>400 IU/day), Nausea and gastrointestinal distress, Fatigue and muscle weakness at very high doses, Potential increased mortality risk at chronic high doses (meta-analysis finding, debated). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Vitamin E and Immune Aging (Immunosenescence)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 5 peer-reviewed studies with 600 total participants. The overall direction of effect is positive.

Related Evidence

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.